98. 好酸球性消化管疾患 Eosinophilic gastrointestinal disease Clinical trials / Disease details


臨床試験数 : 171 薬物数 : 184 - (DrugBank : 47) / 標的遺伝子数 : 42 - 標的パスウェイ数 : 141

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01702701
(ClinicalTrials.gov)
January 20124/10/2012Eosinophilic Esophagitis Treatment: Montelukast vs FluticasoneEosinophilic Esophagitis Treatment: Montelukast vs FluticasoneEosinophilic Esophagitis;DysphagiaDrug: Montelukast;Drug: FluticasoneMedical College of WisconsinNULLWithdrawn18 YearsN/AAll0Phase 3United States
2NCT01458418
(ClinicalTrials.gov)
December 201118/10/2011A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in ChildrenA Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in ChildrenEosinophilic EsophagitisDrug: Montelukast;Other: placebo;Drug: 5 mg MontelukastChildren's Mercy Hospital Kansas CityNULLTerminated2 Years17 YearsAll4N/AUnited States
3NCT00511316
(ClinicalTrials.gov)
August 20071/8/2007Trial of Montelukast in Eosinophilic EsophagitisA Randomized Placebo-Controlled Trial of Montelukast in Maintenance Therapy of Asymptomatic Eosinophilic EsophagitisEosinophilic EsophagitisDrug: Montelukast/ Singulair;Drug: PlaceboMayo ClinicMerck Sharp & Dohme Corp.;Merck Sharp & Dohme Corp.Completed18 Years100 YearsBoth41Phase 1United States
4NCT00148603
(ClinicalTrials.gov)
September 20056/9/2005Montelukast in the Treatment of Duodenal EosinophiliaMontelukast in the Treatment of Duodenal Eosinophilia in Children With Dyspepsia: Effect on Eosinophil Density and Activation in Relation to PharmacokineticsEosinophilic Gastroenteritis;DyspepsiaDrug: montelukastChildren's Mercy Hospital Kansas CityMerck Sharp & Dohme Corp.Completed8 Years17 YearsBoth24N/AUnited States